Retinoblastoma protein expression and radiation response in muscle- invasive bladder cancer

International Journal of Radiation Oncology Biology Physics

Volumn 39, Issue 3, 1997, Pages 687-695

  Pollack, Alan ^a,c   Czerniak, Bogdan ^a   Zagars, Gunar K ^a   Hu, Shi Xue ^a   Wu, Catherine S ^a   Dinney, Colin P N ^a   Chyle, Valerian ^b   Benedict, William F ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b Baptist Hospital   (United States)

^c Department of Radiotherapy ^*  (United States)

Author keywords

Apoptosis; Bladder neoplasm; Immunohistochemistry; p53; pRB; Radiotherapy

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INVASION; CANCER STAGING; CELL CYCLE G1 PHASE; CELL DEATH; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION RESPONSE; TREATMENT OUTCOME; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; PROGNOSIS; PROSTATECTOMY; RETINOBLASTOMA PROTEIN; TUMOR SUPPRESSOR PROTEIN P53; URINARY BLADDER NEOPLASMS;

EID: 0030927984     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(97)00147-8     Document Type: Article

References (34)

1. Altman, D. G. Practical statistics for medical research. London, UK: Chapman and Hall; 1991:179-268.
2. Baird, D. S. F.; Martin, M.; Rhun, Y. L.; Duthu, A.; Lefaix, J. L.; May, E.; May, P. Concomitant p53 mutation and increased radiosensitivity in rat lung embryo epithelial cells during neoplastic development. Cancer Res. 54:3361-3364; 1994.
3. Brachman, D. G.; Beckett, M.; Graves, D.; Haraf, D.; Vokes, E.; Weichselbaum, R. R. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. Cancer Res. 53:3667-3669; 1993.
4. Bryson, M. C.; Johnson, M. E. The incidence of monitone likelihood in the Cox model. Technometrics 23:381-383; 1981.
5. Chuan-Yuan, L.; Nagasawa, H.; Dahlberg, W. K.; Little, J. B. Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established tumor cell lines. Oncogene 11:1885-1892; 1995.
6. Chyle, V.; Pollack, A.; Czerniak, B. A.; Stephens, L. C.; Zagars, G. K.; Terry, N. H. A.; Meyn, R. E. Apoptosis and downstaging after preoperative radiotherapy for muscle-invasive bladder cancer. Int. J. Radiat. Oncol. Biol. Phys. 35:281-287; 1996.
7. Cole, C. J.; Pollack, A.; Zagars, G. K.; Dinney, C. P.; Swanson, D. A.; von Eschenbach, A. C. Local control of muscle-invasive bladder cancer: Preoperative radiotherapy and cystectomy versus cystectomy alone. Int. J. Radiat. Oncol. Biol. Phys. 32:331-340; 1995.
8. Cordon-Cardo C.; Wartinger, D.; Petrylak, D.; Dalbagni, G.; Fair, W. R.; Fuks, Z.; Reuter, V. E. Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J. Natl. Cancer Inst. 84:1251-1256; 1992.
9. Debbas, M.; White, E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 7:546-554; 1993.
10. Dunst, J.; Sauer, R.; Schrott, K. M.; Kuhn, P. D.; Wittekind, C.; Altendorf-Hoffmann, A. Organ-sparing treatment of advanced bladder cancer: A 10-year experience. Int. J. Radiat. Oncol. Biol. Phys. 30:261-266; 1994.
11. Ewen, M. E. The cell cycle and the retinoblastoma protein family. Cancer Metastasis Rev. 13:45-66; 1994.
12. Geradts, J.; Hu, S.-X.; Lincoln, C. E.; Benedict, W. F.; Xu, H.-J. Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti-RB antibodies. Int. J. Cancer 58:161-167; 1994.
13. Goodrich, D. W.; Wang, N. P.; Qian, Y.-W.; Eva, Y. J.; Lee, P.; Lee, W.-H. The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67:293-302; 1991.
14. Haas-Kogan, D. A.; Kogan, S. C.; Levi, D.; Dazin, P.; T'Ang, A.; Fung, Y. K.; Israel, M. A. Inhibition of apoptosis by the retinoblastoma gene product. EMBO J. 14:461-472; 1995.
15. Harris, E. K.; Albert, A. Survivorship analysis for clinical studies. New York: Marcel Dekker Inc.; 1991:5-125.
16. Harper, J. W.; Adami, G. R.; Wei, N.; Keyomarsi, K.; Elledge, S. J. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of cyclin-dependent kinases. Cell 75:805-816; 1993.
17. Housset, M.; Maulard, C.; Chretien, Y. Combined radiation and chemotherapy for invasive transitional-cell carcinoma of the bladder: A prospective study. J. Clin. Oncol. 11:2150-2157; 1993.
18. Jahnson, S.; Risberg, B.; Karlsson, M. G.; Westman, G.; Bergstrom, R.; Pedersen, J. p53 and Rb immunostaining in locally advanced bladder cancer: Relation to prognostic variables and predictive value for the local control response to radical radiotherapy. Eur. Urol. 28:135-142; 1995.
19. Kaufman, D. S.; Shipley, W. U.; Griffin, P. P.; Heney, N. M.; Althausen, A. F.; Efird, J. T. Selective bladder preservation by combination treatment of invasive bladder cancer. N. Engl. J. Med. 329:1377-1382; 1993.
20. Lipponen, P. K.; Liukkonen, T. J. O. Reduced expression of retinoblastoma (Rb) gene protein is related to cell proliferation and prognosis in transitional-cell bladder cancer. J. Cancer Res. Clin. Oncol. 121:44-50; 1995.
21. Logothetis, C. J.; Xu, H.-J.; Ro, J. Y.; Hu, S. X.; Sahin, A.; Ordonez, N.; Benedict, W. F. Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer. J. Natl. Cancer Inst. 84:1256-1261; 1992.
22. Lowe, S. W.; Ruley, H. E.; Jacks, T.; Housman, D. E. p53 dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967; 1993.
23. McIlwrath, A. J.; Vasey, P. A.; Ross, G. M.; Brown, R. Cell cycle arrests and radiosensitivity of human tumor cell lines: Dependence on wild-type p53 for radiosensitivity. Cancer Res 54:3718-3722; 1994.
24. Morgenbesser, S. D.; Williams, B. O.; Jacks, T.; DePinho, R. A. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 371:72-74; 1994.
25. Mostofi, F. J.; Sobin, L. H.; Torlain, H. Histological typing of urinary bladder tumors. Geneva: World Health Organization; 1973.
26. Peacock, J. W.; Chung, S.; Bristow, R. G.; Hill, R. P.; Benchimol, S. The p53-mediated G1 checkpoint is retained in tumorigenic rat embryo fibroblast clones transformed by Papillomavirus type 16 E7 gene and EJ-ras. Mol. Cell. Biol. 15:1446-1454; 1995.
27. Pollack, A.; Zagars, G. K.; Dinney, C. P.; Swanson, D. A.; von Eschenbach, A. C. Preoperative radiotherapy for muscle-invasive bladder cancer: Long term follow-up and prognostic factors for 338 patients. Cancer 74:2819-2827; 1994.
28. Pollack, A.; Zagars, G. Z.; Cole, C. J.; Dinney, C. P. N.; Swanson, D. A.; Grossman, H. B. Significance of downstaging in muscle-invasive bladder cancer treated with preoperative radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 37:41-50; 1997.
29. Slebos, R. J. C.; Lee, M. H.; Plunkett, B. S.; Kessis, T. D.; Williams, B. O.; Jacks, T.; Hedrick, L.; Kastan, M. B.; Cho, K. R. p53-dependent G1 arrest involves pRB-related proteins and is disrupted by human papillomavirus 16 E7 oncoprotein. Proc. Natl. Acad. Sci. USA 91:5320-5324; 1994.
30. Tsang, N.-M.; Little, J. B. Effect of restoration of retinoblastoma gene function on the radiosensitivity of cells of human tumor cell lines. Radiat. Res. 140:172-179; 1994.
31. Wu, C. S.; Pollack, A.; Czerniak, B. A.; Chyle, V.; Zagars, G. K.; Dinney, C. P. N.; Hu, S.-X.; Benedict, W. F. Prognostic value of p53 muscle-invasive bladder cancer treated with preoperative radiotherapy. Urology 47:305-310; 1996.
32. Wu, X.; Levine, A. J. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:3602-3606; 1994.
33. Xu H.-J.; Cairns, P.; Hu, S.-X.; Knowles, M. A.; Benedict, W. F. Loss of RB protein expression in primary bladder can-cer correlates with loss of heterozygosity at the RB locus and tumor progression. Int. J. Cancer 53:781-784; 1993.
34. Yount, G. L.; Haas-Kogan, D. A.; Vidair, C. A.; Haas, M.; Dewey, W. C.; Isreal, M. A. Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells. Cancer Res. 56:500-506; 1996.